viernes, 24 de febrero de 2017

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

No hay comentarios:

Publicar un comentario